Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study
Emília M. Jalil, Thiago S. Torres, Paula M. Luz, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. 3
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study
Valdiléa G. Veloso, Carlos Cáceres, Brenda Hoagland, et al.
The Lancet HIV (2022) Vol. 10, Iss. 2, pp. e84-e96
Open Access | Times Cited: 47
Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study
Kelika A. Konda, Thiago S. Torres, Gabriela Mariño, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. S5
Open Access | Times Cited: 44
Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil
Mayara Secco Torres Silva, Carolina Coutinho, Thiago S. Torres, et al.
The Lancet Regional Health - Americas (2022) Vol. 17, pp. 100406-100406
Open Access | Times Cited: 40
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
Connie Celum, Beatriz Grinsztejn, Kenneth Ngure
Journal of the International AIDS Society (2023) Vol. 26, Iss. S2
Open Access | Times Cited: 25
Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil
Claudia Cristina de Aguiar Pereira, Thiago S. Torres, Paula M. Luz, et al.
The Lancet Regional Health - Americas (2023) Vol. 19, pp. 100432-100432
Open Access | Times Cited: 10
Determinants of Willingness to Use Oral HIV Pre-Exposure Prophylaxis Among Transgender Women in Colombia
Beatriz Alvarado, Julián Andrés Torres-Isasiga, Héctor Fabio Mueses-Marín, et al.
Transgender Health (2025)
Closed Access
Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey
Hamid Vega-Ramírez, Thiago S. Torres, Centli Guillén-Díaz-Barriga, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
Mark A. Marzinke, Brett Hanscom, Zhe Wang, et al.
The Lancet HIV (2023) Vol. 10, Iss. 11, pp. e703-e712
Open Access | Times Cited: 9
A pilot program of HIV pre-exposure prophylaxis in Thai youth
Supattra Rungmaitree, Peerawong Werarak, Wadchara Pumpradit, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298914-e0298914
Open Access | Times Cited: 3
Black Women’s Sexual Well-being in the Age of Pre-Exposure Prophylaxis (PrEP): a Systematic Review of the Literature
Peyton R. Willie, Sannisha K. Dale
Current Sexual Health Reports (2024) Vol. 16, Iss. 3, pp. 138-176
Open Access | Times Cited: 3
No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre‐exposure prophylaxis
Nimish Patel, Sheldon Morris, Leah Burke, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 2
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
Cristina Pimenta, Thiago S. Torres, Brenda Hoagland, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e60961-e60961
Open Access | Times Cited: 2
Oral Pre-Exposure Prophylaxis for HIV Discontinuation in a Large Cohort of Adolescent Men Who Have Sex With Men and Transgender Women in Brazil
Diana Zeballos, Laio Magno, Fabiane Soares, et al.
Journal of Adolescent Health (2023) Vol. 73, Iss. 6, pp. S43-S49
Open Access | Times Cited: 5
Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug–drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis
Vitória Berg Cattani, Emília M. Jalil, Leonardo Eksterman, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 10, pp. 2729-2736
Open Access | Times Cited: 8
Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil
Amanda Echeverría-Guevara, Lara E. Coelho, Valdiléa G. Veloso, et al.
The Brazilian Journal of Infectious Diseases (2022) Vol. 27, Iss. 1, pp. 102733-102733
Open Access | Times Cited: 8
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions
Vitória Berg Cattani, Emília M. Jalil, Leonardo Eksterman, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 7, pp. 1031-1041
Open Access | Times Cited: 4
Reducing intersectional stigma among transgender women in Brazil to promote uptake of HIV testing and PrEP: study protocol for a randomised controlled trial of Manas por Manas
Jae Sevelius, Maria Amélia de Sousa Mascena Veras, José L. Gómez, et al.
BMJ Open (2024) Vol. 14, Iss. 6, pp. e076878-e076878
Open Access | Times Cited: 1
Acesso de pessoas trans e travestis à profilaxia pré-exposição ao HIV no Brasil: estudo descritivo, 2018-2023
Aline Pilon Maurício da Silva, Isabela Ornelas Pereira, Tatianna Meireles Dantas de Alencar, et al.
Epidemiologia e Serviços de Saúde (2024) Vol. 33, Iss. spe1
Open Access | Times Cited: 1
Barriers and facilitators to HIV pre-exposure prophylaxis uptake among transgender women in Colombia: A qualitative analysis using the COM-B model
María Camila Bolívar-Rocha, Sheila Andrea Gómez, Pilar Camargo‐Plazas, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 9, pp. e0001395-e0001395
Open Access | Times Cited: 3
Adherence to Oral Pre-Exposure Prophylaxis Intervention by Transgender Women: A Systematic Review
Jorge Eduardo Moncayo Quevedo, María Del Mar Pérez Arizabaleta, Lina María Villegas-Trujillo, et al.
AIDS Education and Prevention (2023) Vol. 35, Iss. 5, pp. 362-375
Closed Access | Times Cited: 3
Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis
Nathália Sernizon Guimarães, Laio Magno, Gabriel Marinho Bahia Monteiro, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
AIDS, DoençaEmergente Que Permanece
Beatriz Grinsztejn, Emília M. Jalil, V. G. Veloso
Anais da Academia Nacional de Medicina (2023) Vol. 194, Iss. 2, pp. 56-75
Open Access | Times Cited: 1
Access and use of pre-exposure prophylaxis for HIV in the city of Santa Maria, RS
Mileny Rosalina Galvão, Jarbas da Silva Ziani, Bibiana Letícia Nogara, et al.
Disciplinarum Scientia. Série Ciências da Saúde (2024) Vol. 25, Iss. 1, pp. 41-56
Open Access
Perceived Feasibility and Acceptability of HIV Prevention Research With Daily Oral PrEP Among Young Transgender Women (YTGW) Who Sell or Trade Sex in Bangkok and Pattaya, Thailand
Tareerat Chemnasiri, Anchalee Varangrat, Andrea L. Wirtz, et al.
AIDS Education and Prevention (2024) Vol. 36, Iss. 4, pp. 244-260
Open Access
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study (Preprint)
Cristina Pimenta, Thiago S. Torres, Brenda Hoagland, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top